Genzyme and Osiris Partner to Develop and Commercialize First-in-Class Adult Stem Cell Products
|
05 November 2008 |
Genzyme Reports Strong Third-Quarter Sales and Earnings Growth
|
24 October 2008 |
Genzyme Recognized by Scientists as a Top Employer
|
10 October 2008 |
Brings complementary capabilities in India to address patient populations most at risk
|
26 August 2008 |
Genzyme Files Applications for Approval of Mozobil in the United States and Europe
|
19 June 2008 |
Highlight Potential of Novel Oral Compound for Gaucher Disease
|
08 May 2008 |
Genzyme Reports Strong First-Quarter Growth
|
24 April 2008 |
Environmentally Responsible Site to Significantly Increase Company's Presence in China
|
23 April 2008 |
Genzyme Withdraws Bioenvision's European Filing of Evoltra® in Elderly AML Patients
|
20 March 2008 |
Genzyme Launches Renvela® in the U.S. for Dialysis Patients
|
07 March 2008 |
Genzyme Delivers Strong Fourth Quarter to Conclude Outstanding Year
|
13 February 2008 |
Genzyme and Isis Announce Strategic Alliance Including Exclusive Worldwide License of Mipomersen
|
08 January 2008 |